Kumagai Takeshi, Tsutsumi Hiromu, Ogawa Norihiro, Naito Saori, Ebina Keiichi, Yokota Katsushi, Nagata Kiyoshi
Department of Environmental Health Science, Tohoku Pharmaceutical University, Miyagi, Japan.
Biol Pharm Bull. 2006 Nov;29(11):2181-6. doi: 10.1248/bpb.29.2181.
Oxidatively modified low-density lipoprotein (OxLDL) is present in atherosclerotic lesions and has been proposed to play an important role in atherogenesis. In the present study, in order to clarify the structure-binding activity relationship of Asp-hemolysin-related peptides to OxLDL, we investigated the interaction between Asp-hemolysin-related peptides consisting of 4 to 29 amino acid residues and OxLDL. The incubation of OxLDL with each Asp-hemolysin-related peptide resulted in the formation of an Asp-hemolysin/OxLDL complex. In particular, the tetrapeptide, YKDG (P-4), bound to OxLDL and inhibited the OxLDL-induced macrophage proliferation in a dose-dependent manner. Furthermore, we demonstrated that lysophosphatidylcholine (LysoPC) extracted from OxLDL inhibited the binding of P-21 to OxLDL in a dose-dependent manner and synthetic [14C]LysoPC bound to P-21. We propose here that the YKDG region is one of the important sites for the binding of these peptides to OxLDL, and LysoPC as a typical lipid moiety of OxLDL is attributed to the binding of OxLDL to these peptides.
氧化修饰的低密度脂蛋白(OxLDL)存在于动脉粥样硬化病变中,并被认为在动脉粥样硬化的发生发展中起重要作用。在本研究中,为了阐明天冬氨酸溶血素相关肽与OxLDL的结构-结合活性关系,我们研究了由4至29个氨基酸残基组成的天冬氨酸溶血素相关肽与OxLDL之间的相互作用。OxLDL与每种天冬氨酸溶血素相关肽孵育后形成了天冬氨酸溶血素/OxLDL复合物。特别是四肽YKDG(P-4)与OxLDL结合,并以剂量依赖的方式抑制OxLDL诱导的巨噬细胞增殖。此外,我们证明从OxLDL中提取的溶血磷脂酰胆碱(LysoPC)以剂量依赖的方式抑制P-21与OxLDL的结合,并且合成的[14C]LysoPC与P-21结合。我们在此提出,YKDG区域是这些肽与OxLDL结合的重要位点之一,并且LysoPC作为OxLDL的典型脂质部分促成了OxLDL与这些肽的结合。